Contact
searchSearch
HMP Global

News

News
Doxazosin Tablets Recalled Due to Incorrect Tablet Imprint
02/12/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class III recall for doxazosin tablets after a manufacturing error resulted in tablets imprinted with the wrong identifier.
The US Food and Drug Administration (FDA) has issued a Class III recall for doxazosin tablets after a manufacturing error resulted in tablets imprinted with the wrong identifier.
The US Food and Drug...
02/12/2026
Pharmacy Learning Network
News
Testosterone Pellets Recalled Over Potential Contamination
02/12/2026
Hannah Musick
A Class II recall has been issued for multiple lots of testosterone and combination hormone pellets due to the potential presence of particulate matter in implantable hormone therapy products distributed nationwide.
A Class II recall has been issued for multiple lots of testosterone and combination hormone pellets due to the potential presence of particulate matter in implantable hormone therapy products distributed nationwide.
A Class II recall has been...
02/12/2026
Pharmacy Learning Network
News
Asteria Health Estradiol Pellets Recalled Over Potential Metal Contamination
02/12/2026
Hannah Musick
A Class II recall for Asteria Health estradiol sterile pellets has been issued due to the potential presence of metal particulate matter, affecting multiple strengths and lots used in hormone replacement therapy.
A Class II recall for Asteria Health estradiol sterile pellets has been issued due to the potential presence of metal particulate matter, affecting multiple strengths and lots used in hormone replacement therapy.
A Class II recall for Asteria...
02/12/2026
Pharmacy Learning Network
PharmLaw
Novo Nordisk Sues Hims & Hers as FDA Moves to Restrict Compounded GLP-1 Drugs
02/10/2026
Juliet Gallagher
Novo Nordisk has escalated its fight against compounded semaglutide products by filing a patent infringement lawsuit against Hims & Hers Health, while the US Food and Drug Administration (FDA) announced sweeping enforcement actions aimed at...
Novo Nordisk has escalated its fight against compounded semaglutide products by filing a patent infringement lawsuit against Hims & Hers Health, while the US Food and Drug Administration (FDA) announced sweeping enforcement actions aimed at...
Novo Nordisk has escalated its...
02/10/2026
Pharmacy Learning Network
News
Baxter Healthcare Recalls Sterile Water for Irrigation Due to Plastic Particulate Contamination
02/05/2026
Grace Taylor, MS, MA
Baxter Healthcare has issued a voluntary nationwide Class II recall of Sterile Water for Irrigation after plastic particles from the bottle rim were found contaminating the solution.
Baxter Healthcare has issued a voluntary nationwide Class II recall of Sterile Water for Irrigation after plastic particles from the bottle rim were found contaminating the solution.
Baxter Healthcare has issued a...
02/05/2026
Pharmacy Learning Network
News
Recall Issued for Parodontax Active Gum Health Mouthwash Due to Labeling Error
02/05/2026
Grace Taylor, MS, MA
A voluntary Class III recall has been issued for parodontax Active Gum Health Mouthwash after discovering that some bottles may be missing or have illegible lot and expiration date information.
A voluntary Class III recall has been issued for parodontax Active Gum Health Mouthwash after discovering that some bottles may be missing or have illegible lot and expiration date information.
A voluntary Class III recall has...
02/05/2026
Pharmacy Learning Network
PharmLaw
Iowa Attorney General Accuses Insulin Makers and PBMs of Deceptive Pricing Practices
02/03/2026
Juliet Gallagher
Iowa Attorney General Brenna Bird has filed a sweeping lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated, years-long scheme to artificially inflate the prices of insulin and other...
Iowa Attorney General Brenna Bird has filed a sweeping lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated, years-long scheme to artificially inflate the prices of insulin and other...
Iowa Attorney General Brenna...
02/03/2026
Pharmacy Learning Network
News
Antacid Tablets Recalled Due to Failed Disintegration Specifications
01/29/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for INON ACE Antacid Tablets due to failed disintegration specifications, which may reduce the product’s effectiveness in relieving indigestion and gas.
The US Food and Drug Administration (FDA) has issued a Class II recall for INON ACE Antacid Tablets due to failed disintegration specifications, which may reduce the product’s effectiveness in relieving indigestion and gas.
The US Food and Drug...
01/29/2026
Pharmacy Learning Network
News
Glycopyrrolate Oral Solution Recalled Due to Degradation Specification Failure
01/29/2026
Hannah Musick
A Class III recall has been issued for glycopyrrolate oral solution due to degradation/impurity specification failure.
A Class III recall has been issued for glycopyrrolate oral solution due to degradation/impurity specification failure.
A Class III recall has been...
01/29/2026
Pharmacy Learning Network
News
Icosapent Ethyl Capsules Under Class II Recall
01/29/2026
Hannah Musick
The US Food and Drug Administration (FDA) is monitoring a Class II recall of icosapent ethyl capsules after capsule leakage caused subpotency, potentially affecting cardiovascular risk reduction therapy in patients with elevated triglycerides.
The US Food and Drug Administration (FDA) is monitoring a Class II recall of icosapent ethyl capsules after capsule leakage caused subpotency, potentially affecting cardiovascular risk reduction therapy in patients with elevated triglycerides.
The US Food and Drug...
01/29/2026
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use